Tony Eissa
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1) (NCT02116712) | Tony Eissa | 2014-08-01 |
Track Tony Eissa automatically
Every clearance here is in the API, with alerts when new ones post.